Florida Inflammatory Bowel Disease Congress 2026 is organized by Orlando Health Digestive Health Institute and will be held on Apr 18, 2026 at Gaylord Palms Resort & Convention Center, Kissimmee, Florida, United States of America.
Description:
This one-day symposium is packed with clinically relevant information provided in an atmosphere that has been set up for optimal learning. The refreshment break and lunch are conducive for friends and colleagues attending the symposium to connect in a spirit of collegiality and camaraderie. Delegates will find the program to be impactful and to positively invigorate their professional lives
The Orlando Health Center for Inflammatory Bowel Disease (IBD) will host the Florida IBD Congress to highlight the latest advancements in the diagnosis and management of IBD.
This conference is designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD. At the Florida IBD Congress, internationally recognized faculty will provide insight into the latest advancements pertaining to IBD diagnosis, management, and complications and highlight state-of-the-art interventions via a combination of didactic presentations, debates and interactive case-based discussions. The knowledge gained from attending the symposium will allow delegates to implement these changes and thereby significantly improve the quality of their clinical practice. This program is designed for gastroenterologists, gastroenterology fellows, primary care physicians, colo-rectal and general surgeons, nurses, physician assistants, and nurse practitioners interested in the latest information on diagnostic and therapeutic options for patients with IBD. The objective of the Florida IBD Congress is to provide participants a comprehensive education in Inflammatory Bowel Disease evaluation and management.
The program covers six major topics:
Agenda:
| Saturday, April 18, 2026 | ||
| 7:30 – 7:55 am | Registration and Continental Breakfast | |
| 7:55 – 8:00 am | Welcome Address | Udayakumar Navaneethan, MD |
| Session I: Management of IBD | ||
| 8:00 – 8:15 am | Bio-naive UC patient with moderate to severe disease | David T. Rubin, MD |
| 8:15 – 8:30 am | Bio-naive CD patient with moderate to severe disease | Stephen Hanauer, MD |
| 8:30 – 8:45 am | Advances in anti-TNF treatment | Gary R. Lichtenstein, MD |
| 8:45 – 9:05 am | Optimizing the use of anti-interleukins and anti-integrins in IBD | Millie D. Long, MD |
| 9:05 – 9:25 am | Positioning small molecules in the IBD treatment algorithm | David T. Rubin, MD |
| 9:25 – 9:40 am | Combination biologics / small molecules in IBD | David Hudesman, MD |
| 9:40 – 9:55 am | What’s in the IBD pipeline – exciting future | Vipul Jairath, MD |
| 9:55 – 10:30 am | Video case presentations and panel discussion — Choosing treatment options for moderate to severe ulcerative colitis and Crohn’s disease | |
| Session II: Debates in IBD | ||
| 10:45 – 11:05 am | Intestinal Ultrasound in IBD: • Ultrasound should be opening move • Endoscopy is gold standard | Noa Krugliak Cleveland, MD Gary R. Lichtenstein, MD |
| 11:05 – 11:35 am | Dysplasia in IBD: • Endoscopy & resection first • Surgery cures all dysplasia | Partha Pal, MD Marco Ferrara, MD |
| 11:35 – 12:00 pm | Strictures in Crohn’s Disease: • Medicine & endoscopy first • Surgery to fix the stricture | Udayakumar Navaneethan, MD Jean Ashburn, MD |
| 12:00 – 12:25 pm | Complex Perianal CD: • Medicines & endoscopy can avoid surgery • Surgery is the only option | Bo Shen, MD Jean Ashburn, MD |
| 12:25 – 12:45 pm | Video case presentations & panel – Interventional IBD & colorectal surgery | Panel |
| 12:45 – 1:30 pm | Industry-Sponsored Luncheon | |
| Session III: IBD in Special Situations | ||
| 1:30 – 1:45 pm | Acute severe ulcerative colitis | David Hudesman, MD |
| 1:45 – 2:00 pm | Video session: Post-operative anatomy in IBD | Bo Shen, MD |
| 2:00 – 2:20 pm | Newer guidelines on preconception to peripartum IBD management | Mitali Agarwal, MD |
| 2:20 – 2:35 pm | Approach to pouchitis | Bo Shen, MD |
| 2:35 – 3:05 pm | Lifetime in IBD management: 10 clinical pearls | Stephen Hanauer, MD |
| 3:05 – 3:35 pm | Video case presentations & panel discussion | Panel |
| 3:35 – 3:50 pm | Refreshment Break | |
| Session IV: Challenges in IBD Management and the Future | ||
| 3:50 – 4:10 pm | Brian Feagan Memorial Lecture: Personalized medicine in IBD | Vipul Jairath, MD |
| 4:10 – 4:30 pm | State-of-the-art: Managing IBD in 2026 | Millie D. Long, MD |
| 4:30 pm | Panel discussion & concluding remarks | Panel |
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Orlando Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider #4008163.
Physicians
Amedco LLC designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.00 ANCC contact hours.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved